Payer Strategy & Utilization
Expert articles and analysis related to payer strategy & utilization.
AI Summary â Last 30 Days
CMSâs 2027 Medicare Advantage policy cycle is sharpening the strategic tension between tighter plan economics, utilization management oversight, and beneficiary protections: payment and Star Ratings changes are being digested alongside consumer-protection provisions that both expand and roll back prior safeguards, while bipartisan House legislation targets MA prior authorization and denial practices. At the same time, CMSâs AI-enabled WISeR prior authorization model is facing political backlash after reports of care delays in Washington, signaling that automation-driven utilization management will be judged not only on savings but also on access, transparency, and provider burden (Healthcare Dive; KFF). For VBC stakeholders, the broader signal is that downside-risk and population-based payment models remain viableâevidenced by Oncology Care Model savings in poor-prognosis cancers and Maryland global-budget utilization reductionsâbut future models will need stronger safeguards around access, specialty-care appropriateness, and payer/provider accountability.
Related Articles
ACA exchanges will continue to shrink as fewer enrollees pay premiums, analysis suggests
About 14% of ACA enrollees didnât pay premiums in January, a higher rate than usual and one that suggests ACA enrollment will continue to decline, according to Wakely.
Wakely Analysis Signals Significant Enrollment Shifts in ACA Individual Market as 2026 Unfolds
OKEMOS, Mich., April 15, 2026 /PRNewswire/ â Wakely Consulting Group, an HMA Company, today released a new analysis of the Affordable Care Act (ACA) individual market that points to meaningful changes...
Wakely Analysis Signals Significant Enrollment Shifts in ACA Individual Market as 2026 Unfolds
Wakely Analysis Signals Significant Enrollment Shifts in ACA Individual Market as 2026 Unfolds  StreetInsider
Percentage of Enrollees Who Fail to Make ACA Payments Rises to 14%
More insurance claims denials are being overturned upon appeal, study finds
Study authors, who reviewed data from New York, said rising rates of overturned claims suggest that insurersâ claims review processes might not be working as intended, and policymakers should consider...
The Operational Drag of Prior Authorizations and the Moral Hazard Impact on Patients
Prior Authorization Is Source of Greatest Patient Burdens in the Health System, Poll Finds
The ACA exchanges are shaky. This insurer wants in anyway
The ACA exchanges are shaky. This insurer wants in anyway  Modern Healthcare
Payers need to speed up prior authorization for drugs under proposed rule
Health insurers face a prior authorization prescription drug mandate similar to the rule imposed on claims, under a proposal released Friday by the Centers for Medicare & Medicaid Services.CMS is prop...
CMS proposes new deadlines for prior authorizations for drugs
Drugs were left out of a 2024 rule streamlining prior authorizations by making decisions electronic and requiring payers to turn them around more quickly. The Trump administration is looking to addres...